Global Leukocyte Surface Antigen CD47 Supply, Demand and Key Producers, 2026-2032
The global Leukocyte Surface Antigen CD47 market size is expected to reach $ 65.51 million by 2032, rising at a market growth of 9.8% CAGR during the forecast period (2026-2032).
Leukocyte Surface Antigen CD47 refers to a biologically and commercially defined target centered on the CD47 antigen. In the market, the sellable products are usually not the native antigen in the human body itself, but antibodies, recombinant proteins, assay kits, binding reagents, and preclinical or clinical blocking molecules developed around this target. The native molecule is a broadly expressed glycosylated transmembrane protein on the cell surface; commercial forms are commonly clear to slightly opalescent liquids, lyophilized powders, or pre-coated microplate kits. Structurally, it contains an extracellular immunoglobulin-like domain, multiple transmembrane regions, and a short intracellular tail. Its product composition may include mammalian-cell-expressed recombinant protein, hybridoma-derived or recombinantly expressed monoclonal antibodies, fluorescent or enzyme-conjugated antibodies, and engineered fusion proteins. Leukocyte Surface Antigen CD47 products belong to life-science research reagents, immunoassay raw materials, and oncology immunotherapy target-development materials. Key technical requirements include high purity, lot-to-lot consistency, correct conformation, low endotoxin, defined species reactivity, and validated binding activity. Its functional principle is to detect or modulate the interaction between this antigen and phagocyte receptors, supporting cell phenotyping, tissue staining, antibody screening, binding-kinetics testing, tumor-immunology research, and candidate-drug evaluation.
Market opportunities are mainly driven by the extension of oncology immunology from adaptive immune checkpoints to innate immune checkpoints. Leukocyte Surface Antigen CD47 is linked to phagocytosis-suppressive signaling, so it supports basic research, flow-cytometry detection, tissue staining, antibody screening, and candidate-drug evaluation. As combination therapy, biomarker stratification, and low red-blood-cell binding designs become the focus of development, research antibodies, recombinant proteins, binding-assay materials, and preclinical functional antibodies still have room for steady growth. For suppliers, the key opportunity is not ordinary catalog antibodies alone, but high-consistency, low-endotoxin, clone-defined, cross-species-validated, and functionally blocking product portfolios.
The main challenge is that the target is broadly expressed, making the therapeutic window narrower than many tumor-specific targets. Failures, discontinuations, and clinical holds in representative candidate drugs have reset investor expectations and reduced the credibility of early high-growth assumptions. In therapeutic development, major risks include anemia, platelet effects, red-blood-cell binding, insufficient monotherapy efficacy, complex combination strategies, difficult patient enrollment, and delayed commercialization. The research reagent segment is less directly affected, but when drug pipelines contract, demand for screening reagents and translational-research materials can become more project-driven and volatile.
Downstream demand is expected to become more segmented. Basic research, immunology, hematology, and tumor-microenvironment studies will continue to generate routine purchases of antibodies, recombinant proteins, and assay kits, usually in small-batch and multi-specification formats. Drug-development customers will place greater emphasis on traceable manufacturing, functional validation, low endotoxin, cell-binding activity, and customized compatibility with candidate screening. Future growth is more likely to come from high-quality tool products, companion research materials, preclinical efficacy evaluation, and combination-immunotherapy research, rather than from near-term large-scale commercial drug sales.
This report studies the global Leukocyte Surface Antigen CD47 production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Leukocyte Surface Antigen CD47 and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Leukocyte Surface Antigen CD47 that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Leukocyte Surface Antigen CD47 total production and demand, 2021-2032, (K Dose)
Global Leukocyte Surface Antigen CD47 total production value, 2021-2032, (USD Million)
Global Leukocyte Surface Antigen CD47 production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Leukocyte Surface Antigen CD47 consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Leukocyte Surface Antigen CD47 domestic production, consumption, key domestic manufacturers and share
Global Leukocyte Surface Antigen CD47 production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Leukocyte Surface Antigen CD47 production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Leukocyte Surface Antigen CD47 production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Leukocyte Surface Antigen CD47 market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck, BD Biosciences, Bio-Techne, Bio-Rad, Revvity BioLegend, Abcam, Miltenyi Biotec, Cell Signaling Technology, Proteintech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Leukocyte Surface Antigen CD47 market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Leukocyte Surface Antigen CD47 Market, By Region:
1. How big is the global Leukocyte Surface Antigen CD47 market?
2. What is the demand of the global Leukocyte Surface Antigen CD47 market?
3. What is the year over year growth of the global Leukocyte Surface Antigen CD47 market?
4. What is the production and production value of the global Leukocyte Surface Antigen CD47 market?
5. Who are the key producers in the global Leukocyte Surface Antigen CD47 market?
6. What are the growth factors driving the market demand?
Leukocyte Surface Antigen CD47 refers to a biologically and commercially defined target centered on the CD47 antigen. In the market, the sellable products are usually not the native antigen in the human body itself, but antibodies, recombinant proteins, assay kits, binding reagents, and preclinical or clinical blocking molecules developed around this target. The native molecule is a broadly expressed glycosylated transmembrane protein on the cell surface; commercial forms are commonly clear to slightly opalescent liquids, lyophilized powders, or pre-coated microplate kits. Structurally, it contains an extracellular immunoglobulin-like domain, multiple transmembrane regions, and a short intracellular tail. Its product composition may include mammalian-cell-expressed recombinant protein, hybridoma-derived or recombinantly expressed monoclonal antibodies, fluorescent or enzyme-conjugated antibodies, and engineered fusion proteins. Leukocyte Surface Antigen CD47 products belong to life-science research reagents, immunoassay raw materials, and oncology immunotherapy target-development materials. Key technical requirements include high purity, lot-to-lot consistency, correct conformation, low endotoxin, defined species reactivity, and validated binding activity. Its functional principle is to detect or modulate the interaction between this antigen and phagocyte receptors, supporting cell phenotyping, tissue staining, antibody screening, binding-kinetics testing, tumor-immunology research, and candidate-drug evaluation.
Market opportunities are mainly driven by the extension of oncology immunology from adaptive immune checkpoints to innate immune checkpoints. Leukocyte Surface Antigen CD47 is linked to phagocytosis-suppressive signaling, so it supports basic research, flow-cytometry detection, tissue staining, antibody screening, and candidate-drug evaluation. As combination therapy, biomarker stratification, and low red-blood-cell binding designs become the focus of development, research antibodies, recombinant proteins, binding-assay materials, and preclinical functional antibodies still have room for steady growth. For suppliers, the key opportunity is not ordinary catalog antibodies alone, but high-consistency, low-endotoxin, clone-defined, cross-species-validated, and functionally blocking product portfolios.
The main challenge is that the target is broadly expressed, making the therapeutic window narrower than many tumor-specific targets. Failures, discontinuations, and clinical holds in representative candidate drugs have reset investor expectations and reduced the credibility of early high-growth assumptions. In therapeutic development, major risks include anemia, platelet effects, red-blood-cell binding, insufficient monotherapy efficacy, complex combination strategies, difficult patient enrollment, and delayed commercialization. The research reagent segment is less directly affected, but when drug pipelines contract, demand for screening reagents and translational-research materials can become more project-driven and volatile.
Downstream demand is expected to become more segmented. Basic research, immunology, hematology, and tumor-microenvironment studies will continue to generate routine purchases of antibodies, recombinant proteins, and assay kits, usually in small-batch and multi-specification formats. Drug-development customers will place greater emphasis on traceable manufacturing, functional validation, low endotoxin, cell-binding activity, and customized compatibility with candidate screening. Future growth is more likely to come from high-quality tool products, companion research materials, preclinical efficacy evaluation, and combination-immunotherapy research, rather than from near-term large-scale commercial drug sales.
This report studies the global Leukocyte Surface Antigen CD47 production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Leukocyte Surface Antigen CD47 and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Leukocyte Surface Antigen CD47 that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Leukocyte Surface Antigen CD47 total production and demand, 2021-2032, (K Dose)
Global Leukocyte Surface Antigen CD47 total production value, 2021-2032, (USD Million)
Global Leukocyte Surface Antigen CD47 production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Leukocyte Surface Antigen CD47 consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Leukocyte Surface Antigen CD47 domestic production, consumption, key domestic manufacturers and share
Global Leukocyte Surface Antigen CD47 production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Leukocyte Surface Antigen CD47 production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Leukocyte Surface Antigen CD47 production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Leukocyte Surface Antigen CD47 market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck, BD Biosciences, Bio-Techne, Bio-Rad, Revvity BioLegend, Abcam, Miltenyi Biotec, Cell Signaling Technology, Proteintech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Leukocyte Surface Antigen CD47 market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Leukocyte Surface Antigen CD47 Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- B-6H12
- ALX-148
- CC-90002
- PSTx-23
- Others
- Anti-CD47 Antibodies
- Recombinant CD47 Proteins
- CD47 Assay Kits
- Others
- Antibodies
- Fusion Proteins
- Small Molecules and Peptides
- Others
- Mammalian Cell Expression Products
- Hybridoma-derived Products
- Microbial Expression Products
- Others
- Lymphoma
- Ovarian Cancer
- Ischemia Reperfusion Injury
- Kindney Transplant Rejection
- Others
- Thermo Fisher Scientific
- Merck
- BD Biosciences
- Bio-Techne
- Bio-Rad
- Revvity BioLegend
- Abcam
- Miltenyi Biotec
- Cell Signaling Technology
- Proteintech
- Sino Biological
- ACROBiosystems
- MedChemExpress
- OriGene
- Santa Cruz Biotechnology
- Bio X Cell
- Leinco Technologies
- RayBiotech
- Cytek Biosciences
- Biocare Medical
- Creative Biolabs
- BPS Bioscience
- MyBioSource
- Novus Biologicals
- Aviva Systems Biology
- Bioss
- Innovative Research
- Antibodies.com
- Abbexa
- Arigo Biolaboratories
- Abnova
- CUSABIO
- Elabscience
- Boster Biological Technology
- ABclonal
- Sangon Biotech
- Cloud-Clone
- Akeso
- 3D Medicines
- Fapon Biopharma
- Aurigene Oncology
- ALX Oncology
- ImmuneOncia Therapeutics
- Boehringer Ingelheim
1. How big is the global Leukocyte Surface Antigen CD47 market?
2. What is the demand of the global Leukocyte Surface Antigen CD47 market?
3. What is the year over year growth of the global Leukocyte Surface Antigen CD47 market?
4. What is the production and production value of the global Leukocyte Surface Antigen CD47 market?
5. Who are the key producers in the global Leukocyte Surface Antigen CD47 market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Leukocyte Surface Antigen CD47 Introduction
1.2 World Leukocyte Surface Antigen CD47 Supply & Forecast
1.2.1 World Leukocyte Surface Antigen CD47 Production Value (2021 & 2025 & 2032)
1.2.2 World Leukocyte Surface Antigen CD47 Production (2021-2032)
1.2.3 World Leukocyte Surface Antigen CD47 Pricing Trends (2021-2032)
1.3 World Leukocyte Surface Antigen CD47 Production by Region (Based on Production Site)
1.3.1 World Leukocyte Surface Antigen CD47 Production Value by Region (2021-2032)
1.3.2 World Leukocyte Surface Antigen CD47 Production by Region (2021-2032)
1.3.3 World Leukocyte Surface Antigen CD47 Average Price by Region (2021-2032)
1.3.4 North America Leukocyte Surface Antigen CD47 Production (2021-2032)
1.3.5 China Leukocyte Surface Antigen CD47 Production (2021-2032)
1.3.6 Europe Leukocyte Surface Antigen CD47 Production (2021-2032)
1.3.7 India Leukocyte Surface Antigen CD47 Production (2021-2032)
1.3.8 South Korea Leukocyte Surface Antigen CD47 Production (2021-2032)
1.3.9 Taiwan Leukocyte Surface Antigen CD47 Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Leukocyte Surface Antigen CD47 Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Leukocyte Surface Antigen CD47 Major Market Trends
2 DEMAND SUMMARY
2.1 World Leukocyte Surface Antigen CD47 Demand (2021-2032)
2.2 World Leukocyte Surface Antigen CD47 Consumption by Region
2.2.1 World Leukocyte Surface Antigen CD47 Consumption by Region (2021-2026)
2.2.2 World Leukocyte Surface Antigen CD47 Consumption Forecast by Region (2027-2032)
2.3 United States Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.4 China Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.5 Europe Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.6 Japan Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.7 South Korea Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.8 ASEAN Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.9 India Leukocyte Surface Antigen CD47 Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Leukocyte Surface Antigen CD47 Production Value by Manufacturer (2021-2026)
3.2 World Leukocyte Surface Antigen CD47 Production by Manufacturer (2021-2026)
3.3 World Leukocyte Surface Antigen CD47 Average Price by Manufacturer (2021-2026)
3.4 Leukocyte Surface Antigen CD47 Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Leukocyte Surface Antigen CD47 Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Leukocyte Surface Antigen CD47 in 2025
3.5.3 Global Concentration Ratios (CR8) for Leukocyte Surface Antigen CD47 in 2025
3.6 Leukocyte Surface Antigen CD47 Market: Overall Company Footprint Analysis
3.6.1 Leukocyte Surface Antigen CD47 Market: Region Footprint
3.6.2 Leukocyte Surface Antigen CD47 Market: Company Product Type Footprint
3.6.3 Leukocyte Surface Antigen CD47 Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Leukocyte Surface Antigen CD47 Production Value Comparison
4.1.1 United States VS China: Leukocyte Surface Antigen CD47 Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Leukocyte Surface Antigen CD47 Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Leukocyte Surface Antigen CD47 Production Comparison
4.2.1 United States VS China: Leukocyte Surface Antigen CD47 Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Leukocyte Surface Antigen CD47 Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Leukocyte Surface Antigen CD47 Consumption Comparison
4.3.1 United States VS China: Leukocyte Surface Antigen CD47 Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Leukocyte Surface Antigen CD47 Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Leukocyte Surface Antigen CD47 Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Leukocyte Surface Antigen CD47 Production Value (2021-2026)
4.4.3 United States Based Manufacturers Leukocyte Surface Antigen CD47 Production (2021-2026)
4.5 China Based Leukocyte Surface Antigen CD47 Manufacturers and Market Share
4.5.1 China Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Leukocyte Surface Antigen CD47 Production Value (2021-2026)
4.5.3 China Based Manufacturers Leukocyte Surface Antigen CD47 Production (2021-2026)
4.6 Rest of World Based Leukocyte Surface Antigen CD47 Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Leukocyte Surface Antigen CD47 Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 B-6H12
5.2.2 ALX-148
5.2.3 CC-90002
5.2.4 PSTx-23
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Leukocyte Surface Antigen CD47 Production by Type (2021-2032)
5.3.2 World Leukocyte Surface Antigen CD47 Production Value by Type (2021-2032)
5.3.3 World Leukocyte Surface Antigen CD47 Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMMERCIAL PRODUCT FORM
6.1 World Leukocyte Surface Antigen CD47 Market Size Overview by Commercial Product Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Commercial Product Form
6.2.1 Anti-CD47 Antibodies
6.2.2 Recombinant CD47 Proteins
6.2.3 CD47 Assay Kits
6.2.4 Others
6.3 Market Segment by Commercial Product Form
6.3.1 World Leukocyte Surface Antigen CD47 Production by Commercial Product Form (2021-2032)
6.3.2 World Leukocyte Surface Antigen CD47 Production Value by Commercial Product Form (2021-2032)
6.3.3 World Leukocyte Surface Antigen CD47 Average Price by Commercial Product Form (2021-2032)
7 MARKET ANALYSIS BY MOLECULAR MODALITY
7.1 World Leukocyte Surface Antigen CD47 Market Size Overview by Molecular Modality: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Molecular Modality
7.2.1 Antibodies
7.2.2 Fusion Proteins
7.2.3 Small Molecules and Peptides
7.2.4 Others
7.3 Market Segment by Molecular Modality
7.3.1 World Leukocyte Surface Antigen CD47 Production by Molecular Modality (2021-2032)
7.3.2 World Leukocyte Surface Antigen CD47 Production Value by Molecular Modality (2021-2032)
7.3.3 World Leukocyte Surface Antigen CD47 Average Price by Molecular Modality (2021-2032)
8 MARKET ANALYSIS BY MANUFACTURING SYSTEM
8.1 World Leukocyte Surface Antigen CD47 Market Size Overview by Manufacturing System: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Manufacturing System
8.2.1 Mammalian Cell Expression Products
8.2.2 Hybridoma-derived Products
8.2.3 Microbial Expression Products
8.2.4 Others
8.3 Market Segment by Manufacturing System
8.3.1 World Leukocyte Surface Antigen CD47 Production by Manufacturing System (2021-2032)
8.3.2 World Leukocyte Surface Antigen CD47 Production Value by Manufacturing System (2021-2032)
8.3.3 World Leukocyte Surface Antigen CD47 Average Price by Manufacturing System (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Leukocyte Surface Antigen CD47 Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Lymphoma
9.2.2 Ovarian Cancer
9.2.3 Ischemia Reperfusion Injury
9.2.4 Kindney Transplant Rejection
9.2.5 Others
9.3 Market Segment by Application
9.3.1 World Leukocyte Surface Antigen CD47 Production by Application (2021-2032)
9.3.2 World Leukocyte Surface Antigen CD47 Production Value by Application (2021-2032)
9.3.3 World Leukocyte Surface Antigen CD47 Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Thermo Fisher Scientific
10.1.1 Thermo Fisher Scientific Details
10.1.2 Thermo Fisher Scientific Major Business
10.1.3 Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Product and Services
10.1.4 Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Thermo Fisher Scientific Recent Developments/Updates
10.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
10.2 Merck
10.2.1 Merck Details
10.2.2 Merck Major Business
10.2.3 Merck Leukocyte Surface Antigen CD47 Product and Services
10.2.4 Merck Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Merck Recent Developments/Updates
10.2.6 Merck Competitive Strengths & Weaknesses
10.3 BD Biosciences
10.3.1 BD Biosciences Details
10.3.2 BD Biosciences Major Business
10.3.3 BD Biosciences Leukocyte Surface Antigen CD47 Product and Services
10.3.4 BD Biosciences Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 BD Biosciences Recent Developments/Updates
10.3.6 BD Biosciences Competitive Strengths & Weaknesses
10.4 Bio-Techne
10.4.1 Bio-Techne Details
10.4.2 Bio-Techne Major Business
10.4.3 Bio-Techne Leukocyte Surface Antigen CD47 Product and Services
10.4.4 Bio-Techne Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Bio-Techne Recent Developments/Updates
10.4.6 Bio-Techne Competitive Strengths & Weaknesses
10.5 Bio-Rad
10.5.1 Bio-Rad Details
10.5.2 Bio-Rad Major Business
10.5.3 Bio-Rad Leukocyte Surface Antigen CD47 Product and Services
10.5.4 Bio-Rad Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Bio-Rad Recent Developments/Updates
10.5.6 Bio-Rad Competitive Strengths & Weaknesses
10.6 Revvity BioLegend
10.6.1 Revvity BioLegend Details
10.6.2 Revvity BioLegend Major Business
10.6.3 Revvity BioLegend Leukocyte Surface Antigen CD47 Product and Services
10.6.4 Revvity BioLegend Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Revvity BioLegend Recent Developments/Updates
10.6.6 Revvity BioLegend Competitive Strengths & Weaknesses
10.7 Abcam
10.7.1 Abcam Details
10.7.2 Abcam Major Business
10.7.3 Abcam Leukocyte Surface Antigen CD47 Product and Services
10.7.4 Abcam Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Abcam Recent Developments/Updates
10.7.6 Abcam Competitive Strengths & Weaknesses
10.8 Miltenyi Biotec
10.8.1 Miltenyi Biotec Details
10.8.2 Miltenyi Biotec Major Business
10.8.3 Miltenyi Biotec Leukocyte Surface Antigen CD47 Product and Services
10.8.4 Miltenyi Biotec Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Miltenyi Biotec Recent Developments/Updates
10.8.6 Miltenyi Biotec Competitive Strengths & Weaknesses
10.9 Cell Signaling Technology
10.9.1 Cell Signaling Technology Details
10.9.2 Cell Signaling Technology Major Business
10.9.3 Cell Signaling Technology Leukocyte Surface Antigen CD47 Product and Services
10.9.4 Cell Signaling Technology Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Cell Signaling Technology Recent Developments/Updates
10.9.6 Cell Signaling Technology Competitive Strengths & Weaknesses
10.10 Proteintech
10.10.1 Proteintech Details
10.10.2 Proteintech Major Business
10.10.3 Proteintech Leukocyte Surface Antigen CD47 Product and Services
10.10.4 Proteintech Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 Proteintech Recent Developments/Updates
10.10.6 Proteintech Competitive Strengths & Weaknesses
10.11 Sino Biological
10.11.1 Sino Biological Details
10.11.2 Sino Biological Major Business
10.11.3 Sino Biological Leukocyte Surface Antigen CD47 Product and Services
10.11.4 Sino Biological Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.11.5 Sino Biological Recent Developments/Updates
10.11.6 Sino Biological Competitive Strengths & Weaknesses
10.12 ACROBiosystems
10.12.1 ACROBiosystems Details
10.12.2 ACROBiosystems Major Business
10.12.3 ACROBiosystems Leukocyte Surface Antigen CD47 Product and Services
10.12.4 ACROBiosystems Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.12.5 ACROBiosystems Recent Developments/Updates
10.12.6 ACROBiosystems Competitive Strengths & Weaknesses
10.13 MedChemExpress
10.13.1 MedChemExpress Details
10.13.2 MedChemExpress Major Business
10.13.3 MedChemExpress Leukocyte Surface Antigen CD47 Product and Services
10.13.4 MedChemExpress Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.13.5 MedChemExpress Recent Developments/Updates
10.13.6 MedChemExpress Competitive Strengths & Weaknesses
10.14 OriGene
10.14.1 OriGene Details
10.14.2 OriGene Major Business
10.14.3 OriGene Leukocyte Surface Antigen CD47 Product and Services
10.14.4 OriGene Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.14.5 OriGene Recent Developments/Updates
10.14.6 OriGene Competitive Strengths & Weaknesses
10.15 Santa Cruz Biotechnology
10.15.1 Santa Cruz Biotechnology Details
10.15.2 Santa Cruz Biotechnology Major Business
10.15.3 Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Product and Services
10.15.4 Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.15.5 Santa Cruz Biotechnology Recent Developments/Updates
10.15.6 Santa Cruz Biotechnology Competitive Strengths & Weaknesses
10.16 Bio X Cell
10.16.1 Bio X Cell Details
10.16.2 Bio X Cell Major Business
10.16.3 Bio X Cell Leukocyte Surface Antigen CD47 Product and Services
10.16.4 Bio X Cell Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.16.5 Bio X Cell Recent Developments/Updates
10.16.6 Bio X Cell Competitive Strengths & Weaknesses
10.17 Leinco Technologies
10.17.1 Leinco Technologies Details
10.17.2 Leinco Technologies Major Business
10.17.3 Leinco Technologies Leukocyte Surface Antigen CD47 Product and Services
10.17.4 Leinco Technologies Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.17.5 Leinco Technologies Recent Developments/Updates
10.17.6 Leinco Technologies Competitive Strengths & Weaknesses
10.18 RayBiotech
10.18.1 RayBiotech Details
10.18.2 RayBiotech Major Business
10.18.3 RayBiotech Leukocyte Surface Antigen CD47 Product and Services
10.18.4 RayBiotech Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.18.5 RayBiotech Recent Developments/Updates
10.18.6 RayBiotech Competitive Strengths & Weaknesses
10.19 Cytek Biosciences
10.19.1 Cytek Biosciences Details
10.19.2 Cytek Biosciences Major Business
10.19.3 Cytek Biosciences Leukocyte Surface Antigen CD47 Product and Services
10.19.4 Cytek Biosciences Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.19.5 Cytek Biosciences Recent Developments/Updates
10.19.6 Cytek Biosciences Competitive Strengths & Weaknesses
10.20 Biocare Medical
10.20.1 Biocare Medical Details
10.20.2 Biocare Medical Major Business
10.20.3 Biocare Medical Leukocyte Surface Antigen CD47 Product and Services
10.20.4 Biocare Medical Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.20.5 Biocare Medical Recent Developments/Updates
10.20.6 Biocare Medical Competitive Strengths & Weaknesses
10.21 Creative Biolabs
10.21.1 Creative Biolabs Details
10.21.2 Creative Biolabs Major Business
10.21.3 Creative Biolabs Leukocyte Surface Antigen CD47 Product and Services
10.21.4 Creative Biolabs Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.21.5 Creative Biolabs Recent Developments/Updates
10.21.6 Creative Biolabs Competitive Strengths & Weaknesses
10.22 BPS Bioscience
10.22.1 BPS Bioscience Details
10.22.2 BPS Bioscience Major Business
10.22.3 BPS Bioscience Leukocyte Surface Antigen CD47 Product and Services
10.22.4 BPS Bioscience Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.22.5 BPS Bioscience Recent Developments/Updates
10.22.6 BPS Bioscience Competitive Strengths & Weaknesses
10.23 MyBioSource
10.23.1 MyBioSource Details
10.23.2 MyBioSource Major Business
10.23.3 MyBioSource Leukocyte Surface Antigen CD47 Product and Services
10.23.4 MyBioSource Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.23.5 MyBioSource Recent Developments/Updates
10.23.6 MyBioSource Competitive Strengths & Weaknesses
10.24 Novus Biologicals
10.24.1 Novus Biologicals Details
10.24.2 Novus Biologicals Major Business
10.24.3 Novus Biologicals Leukocyte Surface Antigen CD47 Product and Services
10.24.4 Novus Biologicals Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.24.5 Novus Biologicals Recent Developments/Updates
10.24.6 Novus Biologicals Competitive Strengths & Weaknesses
10.25 Aviva Systems Biology
10.25.1 Aviva Systems Biology Details
10.25.2 Aviva Systems Biology Major Business
10.25.3 Aviva Systems Biology Leukocyte Surface Antigen CD47 Product and Services
10.25.4 Aviva Systems Biology Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.25.5 Aviva Systems Biology Recent Developments/Updates
10.25.6 Aviva Systems Biology Competitive Strengths & Weaknesses
10.26 Bioss
10.26.1 Bioss Details
10.26.2 Bioss Major Business
10.26.3 Bioss Leukocyte Surface Antigen CD47 Product and Services
10.26.4 Bioss Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.26.5 Bioss Recent Developments/Updates
10.26.6 Bioss Competitive Strengths & Weaknesses
10.27 Innovative Research
10.27.1 Innovative Research Details
10.27.2 Innovative Research Major Business
10.27.3 Innovative Research Leukocyte Surface Antigen CD47 Product and Services
10.27.4 Innovative Research Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.27.5 Innovative Research Recent Developments/Updates
10.27.6 Innovative Research Competitive Strengths & Weaknesses
10.28 Antibodies.com
10.28.1 Antibodies.com Details
10.28.2 Antibodies.com Major Business
10.28.3 Antibodies.com Leukocyte Surface Antigen CD47 Product and Services
10.28.4 Antibodies.com Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.28.5 Antibodies.com Recent Developments/Updates
10.28.6 Antibodies.com Competitive Strengths & Weaknesses
10.29 Abbexa
10.29.1 Abbexa Details
10.29.2 Abbexa Major Business
10.29.3 Abbexa Leukocyte Surface Antigen CD47 Product and Services
10.29.4 Abbexa Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.29.5 Abbexa Recent Developments/Updates
10.29.6 Abbexa Competitive Strengths & Weaknesses
10.30 Arigo Biolaboratories
10.30.1 Arigo Biolaboratories Details
10.30.2 Arigo Biolaboratories Major Business
10.30.3 Arigo Biolaboratories Leukocyte Surface Antigen CD47 Product and Services
10.30.4 Arigo Biolaboratories Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.30.5 Arigo Biolaboratories Recent Developments/Updates
10.30.6 Arigo Biolaboratories Competitive Strengths & Weaknesses
10.31 Abnova
10.31.1 Abnova Details
10.31.2 Abnova Major Business
10.31.3 Abnova Leukocyte Surface Antigen CD47 Product and Services
10.31.4 Abnova Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.31.5 Abnova Recent Developments/Updates
10.31.6 Abnova Competitive Strengths & Weaknesses
10.32 CUSABIO
10.32.1 CUSABIO Details
10.32.2 CUSABIO Major Business
10.32.3 CUSABIO Leukocyte Surface Antigen CD47 Product and Services
10.32.4 CUSABIO Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.32.5 CUSABIO Recent Developments/Updates
10.32.6 CUSABIO Competitive Strengths & Weaknesses
10.33 Elabscience
10.33.1 Elabscience Details
10.33.2 Elabscience Major Business
10.33.3 Elabscience Leukocyte Surface Antigen CD47 Product and Services
10.33.4 Elabscience Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.33.5 Elabscience Recent Developments/Updates
10.33.6 Elabscience Competitive Strengths & Weaknesses
10.34 Boster Biological Technology
10.34.1 Boster Biological Technology Details
10.34.2 Boster Biological Technology Major Business
10.34.3 Boster Biological Technology Leukocyte Surface Antigen CD47 Product and Services
10.34.4 Boster Biological Technology Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.34.5 Boster Biological Technology Recent Developments/Updates
10.34.6 Boster Biological Technology Competitive Strengths & Weaknesses
10.35 ABclonal
10.35.1 ABclonal Details
10.35.2 ABclonal Major Business
10.35.3 ABclonal Leukocyte Surface Antigen CD47 Product and Services
10.35.4 ABclonal Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.35.5 ABclonal Recent Developments/Updates
10.35.6 ABclonal Competitive Strengths & Weaknesses
10.36 Sangon Biotech
10.36.1 Sangon Biotech Details
10.36.2 Sangon Biotech Major Business
10.36.3 Sangon Biotech Leukocyte Surface Antigen CD47 Product and Services
10.36.4 Sangon Biotech Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.36.5 Sangon Biotech Recent Developments/Updates
10.36.6 Sangon Biotech Competitive Strengths & Weaknesses
10.37 Cloud-Clone
10.37.1 Cloud-Clone Details
10.37.2 Cloud-Clone Major Business
10.37.3 Cloud-Clone Leukocyte Surface Antigen CD47 Product and Services
10.37.4 Cloud-Clone Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.37.5 Cloud-Clone Recent Developments/Updates
10.37.6 Cloud-Clone Competitive Strengths & Weaknesses
10.38 Akeso
10.38.1 Akeso Details
10.38.2 Akeso Major Business
10.38.3 Akeso Leukocyte Surface Antigen CD47 Product and Services
10.38.4 Akeso Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.38.5 Akeso Recent Developments/Updates
10.38.6 Akeso Competitive Strengths & Weaknesses
10.39 3D Medicines
10.39.1 3D Medicines Details
10.39.2 3D Medicines Major Business
10.39.3 3D Medicines Leukocyte Surface Antigen CD47 Product and Services
10.39.4 3D Medicines Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.39.5 3D Medicines Recent Developments/Updates
10.39.6 3D Medicines Competitive Strengths & Weaknesses
10.40 Fapon Biopharma
10.40.1 Fapon Biopharma Details
10.40.2 Fapon Biopharma Major Business
10.40.3 Fapon Biopharma Leukocyte Surface Antigen CD47 Product and Services
10.40.4 Fapon Biopharma Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.40.5 Fapon Biopharma Recent Developments/Updates
10.40.6 Fapon Biopharma Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Leukocyte Surface Antigen CD47 Industry Chain
11.2 Leukocyte Surface Antigen CD47 Upstream Analysis
11.2.1 Leukocyte Surface Antigen CD47 Core Raw Materials
11.2.2 Main Manufacturers of Leukocyte Surface Antigen CD47 Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Leukocyte Surface Antigen CD47 Production Mode
11.6 Leukocyte Surface Antigen CD47 Procurement Model
11.7 Leukocyte Surface Antigen CD47 Industry Sales Model and Sales Channels
11.7.1 Leukocyte Surface Antigen CD47 Sales Model
11.7.2 Leukocyte Surface Antigen CD47 Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Leukocyte Surface Antigen CD47 Introduction
1.2 World Leukocyte Surface Antigen CD47 Supply & Forecast
1.2.1 World Leukocyte Surface Antigen CD47 Production Value (2021 & 2025 & 2032)
1.2.2 World Leukocyte Surface Antigen CD47 Production (2021-2032)
1.2.3 World Leukocyte Surface Antigen CD47 Pricing Trends (2021-2032)
1.3 World Leukocyte Surface Antigen CD47 Production by Region (Based on Production Site)
1.3.1 World Leukocyte Surface Antigen CD47 Production Value by Region (2021-2032)
1.3.2 World Leukocyte Surface Antigen CD47 Production by Region (2021-2032)
1.3.3 World Leukocyte Surface Antigen CD47 Average Price by Region (2021-2032)
1.3.4 North America Leukocyte Surface Antigen CD47 Production (2021-2032)
1.3.5 China Leukocyte Surface Antigen CD47 Production (2021-2032)
1.3.6 Europe Leukocyte Surface Antigen CD47 Production (2021-2032)
1.3.7 India Leukocyte Surface Antigen CD47 Production (2021-2032)
1.3.8 South Korea Leukocyte Surface Antigen CD47 Production (2021-2032)
1.3.9 Taiwan Leukocyte Surface Antigen CD47 Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Leukocyte Surface Antigen CD47 Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Leukocyte Surface Antigen CD47 Major Market Trends
2 DEMAND SUMMARY
2.1 World Leukocyte Surface Antigen CD47 Demand (2021-2032)
2.2 World Leukocyte Surface Antigen CD47 Consumption by Region
2.2.1 World Leukocyte Surface Antigen CD47 Consumption by Region (2021-2026)
2.2.2 World Leukocyte Surface Antigen CD47 Consumption Forecast by Region (2027-2032)
2.3 United States Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.4 China Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.5 Europe Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.6 Japan Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.7 South Korea Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.8 ASEAN Leukocyte Surface Antigen CD47 Consumption (2021-2032)
2.9 India Leukocyte Surface Antigen CD47 Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Leukocyte Surface Antigen CD47 Production Value by Manufacturer (2021-2026)
3.2 World Leukocyte Surface Antigen CD47 Production by Manufacturer (2021-2026)
3.3 World Leukocyte Surface Antigen CD47 Average Price by Manufacturer (2021-2026)
3.4 Leukocyte Surface Antigen CD47 Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Leukocyte Surface Antigen CD47 Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Leukocyte Surface Antigen CD47 in 2025
3.5.3 Global Concentration Ratios (CR8) for Leukocyte Surface Antigen CD47 in 2025
3.6 Leukocyte Surface Antigen CD47 Market: Overall Company Footprint Analysis
3.6.1 Leukocyte Surface Antigen CD47 Market: Region Footprint
3.6.2 Leukocyte Surface Antigen CD47 Market: Company Product Type Footprint
3.6.3 Leukocyte Surface Antigen CD47 Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Leukocyte Surface Antigen CD47 Production Value Comparison
4.1.1 United States VS China: Leukocyte Surface Antigen CD47 Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Leukocyte Surface Antigen CD47 Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Leukocyte Surface Antigen CD47 Production Comparison
4.2.1 United States VS China: Leukocyte Surface Antigen CD47 Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Leukocyte Surface Antigen CD47 Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Leukocyte Surface Antigen CD47 Consumption Comparison
4.3.1 United States VS China: Leukocyte Surface Antigen CD47 Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Leukocyte Surface Antigen CD47 Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Leukocyte Surface Antigen CD47 Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Leukocyte Surface Antigen CD47 Production Value (2021-2026)
4.4.3 United States Based Manufacturers Leukocyte Surface Antigen CD47 Production (2021-2026)
4.5 China Based Leukocyte Surface Antigen CD47 Manufacturers and Market Share
4.5.1 China Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Leukocyte Surface Antigen CD47 Production Value (2021-2026)
4.5.3 China Based Manufacturers Leukocyte Surface Antigen CD47 Production (2021-2026)
4.6 Rest of World Based Leukocyte Surface Antigen CD47 Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Leukocyte Surface Antigen CD47 Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 B-6H12
5.2.2 ALX-148
5.2.3 CC-90002
5.2.4 PSTx-23
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Leukocyte Surface Antigen CD47 Production by Type (2021-2032)
5.3.2 World Leukocyte Surface Antigen CD47 Production Value by Type (2021-2032)
5.3.3 World Leukocyte Surface Antigen CD47 Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMMERCIAL PRODUCT FORM
6.1 World Leukocyte Surface Antigen CD47 Market Size Overview by Commercial Product Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Commercial Product Form
6.2.1 Anti-CD47 Antibodies
6.2.2 Recombinant CD47 Proteins
6.2.3 CD47 Assay Kits
6.2.4 Others
6.3 Market Segment by Commercial Product Form
6.3.1 World Leukocyte Surface Antigen CD47 Production by Commercial Product Form (2021-2032)
6.3.2 World Leukocyte Surface Antigen CD47 Production Value by Commercial Product Form (2021-2032)
6.3.3 World Leukocyte Surface Antigen CD47 Average Price by Commercial Product Form (2021-2032)
7 MARKET ANALYSIS BY MOLECULAR MODALITY
7.1 World Leukocyte Surface Antigen CD47 Market Size Overview by Molecular Modality: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Molecular Modality
7.2.1 Antibodies
7.2.2 Fusion Proteins
7.2.3 Small Molecules and Peptides
7.2.4 Others
7.3 Market Segment by Molecular Modality
7.3.1 World Leukocyte Surface Antigen CD47 Production by Molecular Modality (2021-2032)
7.3.2 World Leukocyte Surface Antigen CD47 Production Value by Molecular Modality (2021-2032)
7.3.3 World Leukocyte Surface Antigen CD47 Average Price by Molecular Modality (2021-2032)
8 MARKET ANALYSIS BY MANUFACTURING SYSTEM
8.1 World Leukocyte Surface Antigen CD47 Market Size Overview by Manufacturing System: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Manufacturing System
8.2.1 Mammalian Cell Expression Products
8.2.2 Hybridoma-derived Products
8.2.3 Microbial Expression Products
8.2.4 Others
8.3 Market Segment by Manufacturing System
8.3.1 World Leukocyte Surface Antigen CD47 Production by Manufacturing System (2021-2032)
8.3.2 World Leukocyte Surface Antigen CD47 Production Value by Manufacturing System (2021-2032)
8.3.3 World Leukocyte Surface Antigen CD47 Average Price by Manufacturing System (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Leukocyte Surface Antigen CD47 Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Lymphoma
9.2.2 Ovarian Cancer
9.2.3 Ischemia Reperfusion Injury
9.2.4 Kindney Transplant Rejection
9.2.5 Others
9.3 Market Segment by Application
9.3.1 World Leukocyte Surface Antigen CD47 Production by Application (2021-2032)
9.3.2 World Leukocyte Surface Antigen CD47 Production Value by Application (2021-2032)
9.3.3 World Leukocyte Surface Antigen CD47 Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Thermo Fisher Scientific
10.1.1 Thermo Fisher Scientific Details
10.1.2 Thermo Fisher Scientific Major Business
10.1.3 Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Product and Services
10.1.4 Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Thermo Fisher Scientific Recent Developments/Updates
10.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
10.2 Merck
10.2.1 Merck Details
10.2.2 Merck Major Business
10.2.3 Merck Leukocyte Surface Antigen CD47 Product and Services
10.2.4 Merck Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Merck Recent Developments/Updates
10.2.6 Merck Competitive Strengths & Weaknesses
10.3 BD Biosciences
10.3.1 BD Biosciences Details
10.3.2 BD Biosciences Major Business
10.3.3 BD Biosciences Leukocyte Surface Antigen CD47 Product and Services
10.3.4 BD Biosciences Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 BD Biosciences Recent Developments/Updates
10.3.6 BD Biosciences Competitive Strengths & Weaknesses
10.4 Bio-Techne
10.4.1 Bio-Techne Details
10.4.2 Bio-Techne Major Business
10.4.3 Bio-Techne Leukocyte Surface Antigen CD47 Product and Services
10.4.4 Bio-Techne Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Bio-Techne Recent Developments/Updates
10.4.6 Bio-Techne Competitive Strengths & Weaknesses
10.5 Bio-Rad
10.5.1 Bio-Rad Details
10.5.2 Bio-Rad Major Business
10.5.3 Bio-Rad Leukocyte Surface Antigen CD47 Product and Services
10.5.4 Bio-Rad Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Bio-Rad Recent Developments/Updates
10.5.6 Bio-Rad Competitive Strengths & Weaknesses
10.6 Revvity BioLegend
10.6.1 Revvity BioLegend Details
10.6.2 Revvity BioLegend Major Business
10.6.3 Revvity BioLegend Leukocyte Surface Antigen CD47 Product and Services
10.6.4 Revvity BioLegend Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Revvity BioLegend Recent Developments/Updates
10.6.6 Revvity BioLegend Competitive Strengths & Weaknesses
10.7 Abcam
10.7.1 Abcam Details
10.7.2 Abcam Major Business
10.7.3 Abcam Leukocyte Surface Antigen CD47 Product and Services
10.7.4 Abcam Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Abcam Recent Developments/Updates
10.7.6 Abcam Competitive Strengths & Weaknesses
10.8 Miltenyi Biotec
10.8.1 Miltenyi Biotec Details
10.8.2 Miltenyi Biotec Major Business
10.8.3 Miltenyi Biotec Leukocyte Surface Antigen CD47 Product and Services
10.8.4 Miltenyi Biotec Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Miltenyi Biotec Recent Developments/Updates
10.8.6 Miltenyi Biotec Competitive Strengths & Weaknesses
10.9 Cell Signaling Technology
10.9.1 Cell Signaling Technology Details
10.9.2 Cell Signaling Technology Major Business
10.9.3 Cell Signaling Technology Leukocyte Surface Antigen CD47 Product and Services
10.9.4 Cell Signaling Technology Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Cell Signaling Technology Recent Developments/Updates
10.9.6 Cell Signaling Technology Competitive Strengths & Weaknesses
10.10 Proteintech
10.10.1 Proteintech Details
10.10.2 Proteintech Major Business
10.10.3 Proteintech Leukocyte Surface Antigen CD47 Product and Services
10.10.4 Proteintech Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 Proteintech Recent Developments/Updates
10.10.6 Proteintech Competitive Strengths & Weaknesses
10.11 Sino Biological
10.11.1 Sino Biological Details
10.11.2 Sino Biological Major Business
10.11.3 Sino Biological Leukocyte Surface Antigen CD47 Product and Services
10.11.4 Sino Biological Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.11.5 Sino Biological Recent Developments/Updates
10.11.6 Sino Biological Competitive Strengths & Weaknesses
10.12 ACROBiosystems
10.12.1 ACROBiosystems Details
10.12.2 ACROBiosystems Major Business
10.12.3 ACROBiosystems Leukocyte Surface Antigen CD47 Product and Services
10.12.4 ACROBiosystems Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.12.5 ACROBiosystems Recent Developments/Updates
10.12.6 ACROBiosystems Competitive Strengths & Weaknesses
10.13 MedChemExpress
10.13.1 MedChemExpress Details
10.13.2 MedChemExpress Major Business
10.13.3 MedChemExpress Leukocyte Surface Antigen CD47 Product and Services
10.13.4 MedChemExpress Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.13.5 MedChemExpress Recent Developments/Updates
10.13.6 MedChemExpress Competitive Strengths & Weaknesses
10.14 OriGene
10.14.1 OriGene Details
10.14.2 OriGene Major Business
10.14.3 OriGene Leukocyte Surface Antigen CD47 Product and Services
10.14.4 OriGene Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.14.5 OriGene Recent Developments/Updates
10.14.6 OriGene Competitive Strengths & Weaknesses
10.15 Santa Cruz Biotechnology
10.15.1 Santa Cruz Biotechnology Details
10.15.2 Santa Cruz Biotechnology Major Business
10.15.3 Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Product and Services
10.15.4 Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.15.5 Santa Cruz Biotechnology Recent Developments/Updates
10.15.6 Santa Cruz Biotechnology Competitive Strengths & Weaknesses
10.16 Bio X Cell
10.16.1 Bio X Cell Details
10.16.2 Bio X Cell Major Business
10.16.3 Bio X Cell Leukocyte Surface Antigen CD47 Product and Services
10.16.4 Bio X Cell Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.16.5 Bio X Cell Recent Developments/Updates
10.16.6 Bio X Cell Competitive Strengths & Weaknesses
10.17 Leinco Technologies
10.17.1 Leinco Technologies Details
10.17.2 Leinco Technologies Major Business
10.17.3 Leinco Technologies Leukocyte Surface Antigen CD47 Product and Services
10.17.4 Leinco Technologies Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.17.5 Leinco Technologies Recent Developments/Updates
10.17.6 Leinco Technologies Competitive Strengths & Weaknesses
10.18 RayBiotech
10.18.1 RayBiotech Details
10.18.2 RayBiotech Major Business
10.18.3 RayBiotech Leukocyte Surface Antigen CD47 Product and Services
10.18.4 RayBiotech Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.18.5 RayBiotech Recent Developments/Updates
10.18.6 RayBiotech Competitive Strengths & Weaknesses
10.19 Cytek Biosciences
10.19.1 Cytek Biosciences Details
10.19.2 Cytek Biosciences Major Business
10.19.3 Cytek Biosciences Leukocyte Surface Antigen CD47 Product and Services
10.19.4 Cytek Biosciences Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.19.5 Cytek Biosciences Recent Developments/Updates
10.19.6 Cytek Biosciences Competitive Strengths & Weaknesses
10.20 Biocare Medical
10.20.1 Biocare Medical Details
10.20.2 Biocare Medical Major Business
10.20.3 Biocare Medical Leukocyte Surface Antigen CD47 Product and Services
10.20.4 Biocare Medical Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.20.5 Biocare Medical Recent Developments/Updates
10.20.6 Biocare Medical Competitive Strengths & Weaknesses
10.21 Creative Biolabs
10.21.1 Creative Biolabs Details
10.21.2 Creative Biolabs Major Business
10.21.3 Creative Biolabs Leukocyte Surface Antigen CD47 Product and Services
10.21.4 Creative Biolabs Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.21.5 Creative Biolabs Recent Developments/Updates
10.21.6 Creative Biolabs Competitive Strengths & Weaknesses
10.22 BPS Bioscience
10.22.1 BPS Bioscience Details
10.22.2 BPS Bioscience Major Business
10.22.3 BPS Bioscience Leukocyte Surface Antigen CD47 Product and Services
10.22.4 BPS Bioscience Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.22.5 BPS Bioscience Recent Developments/Updates
10.22.6 BPS Bioscience Competitive Strengths & Weaknesses
10.23 MyBioSource
10.23.1 MyBioSource Details
10.23.2 MyBioSource Major Business
10.23.3 MyBioSource Leukocyte Surface Antigen CD47 Product and Services
10.23.4 MyBioSource Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.23.5 MyBioSource Recent Developments/Updates
10.23.6 MyBioSource Competitive Strengths & Weaknesses
10.24 Novus Biologicals
10.24.1 Novus Biologicals Details
10.24.2 Novus Biologicals Major Business
10.24.3 Novus Biologicals Leukocyte Surface Antigen CD47 Product and Services
10.24.4 Novus Biologicals Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.24.5 Novus Biologicals Recent Developments/Updates
10.24.6 Novus Biologicals Competitive Strengths & Weaknesses
10.25 Aviva Systems Biology
10.25.1 Aviva Systems Biology Details
10.25.2 Aviva Systems Biology Major Business
10.25.3 Aviva Systems Biology Leukocyte Surface Antigen CD47 Product and Services
10.25.4 Aviva Systems Biology Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.25.5 Aviva Systems Biology Recent Developments/Updates
10.25.6 Aviva Systems Biology Competitive Strengths & Weaknesses
10.26 Bioss
10.26.1 Bioss Details
10.26.2 Bioss Major Business
10.26.3 Bioss Leukocyte Surface Antigen CD47 Product and Services
10.26.4 Bioss Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.26.5 Bioss Recent Developments/Updates
10.26.6 Bioss Competitive Strengths & Weaknesses
10.27 Innovative Research
10.27.1 Innovative Research Details
10.27.2 Innovative Research Major Business
10.27.3 Innovative Research Leukocyte Surface Antigen CD47 Product and Services
10.27.4 Innovative Research Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.27.5 Innovative Research Recent Developments/Updates
10.27.6 Innovative Research Competitive Strengths & Weaknesses
10.28 Antibodies.com
10.28.1 Antibodies.com Details
10.28.2 Antibodies.com Major Business
10.28.3 Antibodies.com Leukocyte Surface Antigen CD47 Product and Services
10.28.4 Antibodies.com Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.28.5 Antibodies.com Recent Developments/Updates
10.28.6 Antibodies.com Competitive Strengths & Weaknesses
10.29 Abbexa
10.29.1 Abbexa Details
10.29.2 Abbexa Major Business
10.29.3 Abbexa Leukocyte Surface Antigen CD47 Product and Services
10.29.4 Abbexa Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.29.5 Abbexa Recent Developments/Updates
10.29.6 Abbexa Competitive Strengths & Weaknesses
10.30 Arigo Biolaboratories
10.30.1 Arigo Biolaboratories Details
10.30.2 Arigo Biolaboratories Major Business
10.30.3 Arigo Biolaboratories Leukocyte Surface Antigen CD47 Product and Services
10.30.4 Arigo Biolaboratories Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.30.5 Arigo Biolaboratories Recent Developments/Updates
10.30.6 Arigo Biolaboratories Competitive Strengths & Weaknesses
10.31 Abnova
10.31.1 Abnova Details
10.31.2 Abnova Major Business
10.31.3 Abnova Leukocyte Surface Antigen CD47 Product and Services
10.31.4 Abnova Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.31.5 Abnova Recent Developments/Updates
10.31.6 Abnova Competitive Strengths & Weaknesses
10.32 CUSABIO
10.32.1 CUSABIO Details
10.32.2 CUSABIO Major Business
10.32.3 CUSABIO Leukocyte Surface Antigen CD47 Product and Services
10.32.4 CUSABIO Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.32.5 CUSABIO Recent Developments/Updates
10.32.6 CUSABIO Competitive Strengths & Weaknesses
10.33 Elabscience
10.33.1 Elabscience Details
10.33.2 Elabscience Major Business
10.33.3 Elabscience Leukocyte Surface Antigen CD47 Product and Services
10.33.4 Elabscience Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.33.5 Elabscience Recent Developments/Updates
10.33.6 Elabscience Competitive Strengths & Weaknesses
10.34 Boster Biological Technology
10.34.1 Boster Biological Technology Details
10.34.2 Boster Biological Technology Major Business
10.34.3 Boster Biological Technology Leukocyte Surface Antigen CD47 Product and Services
10.34.4 Boster Biological Technology Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.34.5 Boster Biological Technology Recent Developments/Updates
10.34.6 Boster Biological Technology Competitive Strengths & Weaknesses
10.35 ABclonal
10.35.1 ABclonal Details
10.35.2 ABclonal Major Business
10.35.3 ABclonal Leukocyte Surface Antigen CD47 Product and Services
10.35.4 ABclonal Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.35.5 ABclonal Recent Developments/Updates
10.35.6 ABclonal Competitive Strengths & Weaknesses
10.36 Sangon Biotech
10.36.1 Sangon Biotech Details
10.36.2 Sangon Biotech Major Business
10.36.3 Sangon Biotech Leukocyte Surface Antigen CD47 Product and Services
10.36.4 Sangon Biotech Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.36.5 Sangon Biotech Recent Developments/Updates
10.36.6 Sangon Biotech Competitive Strengths & Weaknesses
10.37 Cloud-Clone
10.37.1 Cloud-Clone Details
10.37.2 Cloud-Clone Major Business
10.37.3 Cloud-Clone Leukocyte Surface Antigen CD47 Product and Services
10.37.4 Cloud-Clone Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.37.5 Cloud-Clone Recent Developments/Updates
10.37.6 Cloud-Clone Competitive Strengths & Weaknesses
10.38 Akeso
10.38.1 Akeso Details
10.38.2 Akeso Major Business
10.38.3 Akeso Leukocyte Surface Antigen CD47 Product and Services
10.38.4 Akeso Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.38.5 Akeso Recent Developments/Updates
10.38.6 Akeso Competitive Strengths & Weaknesses
10.39 3D Medicines
10.39.1 3D Medicines Details
10.39.2 3D Medicines Major Business
10.39.3 3D Medicines Leukocyte Surface Antigen CD47 Product and Services
10.39.4 3D Medicines Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.39.5 3D Medicines Recent Developments/Updates
10.39.6 3D Medicines Competitive Strengths & Weaknesses
10.40 Fapon Biopharma
10.40.1 Fapon Biopharma Details
10.40.2 Fapon Biopharma Major Business
10.40.3 Fapon Biopharma Leukocyte Surface Antigen CD47 Product and Services
10.40.4 Fapon Biopharma Leukocyte Surface Antigen CD47 Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.40.5 Fapon Biopharma Recent Developments/Updates
10.40.6 Fapon Biopharma Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Leukocyte Surface Antigen CD47 Industry Chain
11.2 Leukocyte Surface Antigen CD47 Upstream Analysis
11.2.1 Leukocyte Surface Antigen CD47 Core Raw Materials
11.2.2 Main Manufacturers of Leukocyte Surface Antigen CD47 Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Leukocyte Surface Antigen CD47 Production Mode
11.6 Leukocyte Surface Antigen CD47 Procurement Model
11.7 Leukocyte Surface Antigen CD47 Industry Sales Model and Sales Channels
11.7.1 Leukocyte Surface Antigen CD47 Sales Model
11.7.2 Leukocyte Surface Antigen CD47 Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Leukocyte Surface Antigen CD47 Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Leukocyte Surface Antigen CD47 Production Value by Region (2021-2026) & (USD Million)
Table 3. World Leukocyte Surface Antigen CD47 Production Value by Region (2027-2032) & (USD Million)
Table 4. World Leukocyte Surface Antigen CD47 Production Value Market Share by Region (2021-2026)
Table 5. World Leukocyte Surface Antigen CD47 Production Value Market Share by Region (2027-2032)
Table 6. World Leukocyte Surface Antigen CD47 Production by Region (2021-2026) & (K Dose)
Table 7. World Leukocyte Surface Antigen CD47 Production by Region (2027-2032) & (K Dose)
Table 8. World Leukocyte Surface Antigen CD47 Production Market Share by Region (2021-2026)
Table 9. World Leukocyte Surface Antigen CD47 Production Market Share by Region (2027-2032)
Table 10. World Leukocyte Surface Antigen CD47 Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Leukocyte Surface Antigen CD47 Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Leukocyte Surface Antigen CD47 Major Market Trends
Table 13. World Leukocyte Surface Antigen CD47 Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Leukocyte Surface Antigen CD47 Consumption by Region (2021-2026) & (K Dose)
Table 15. World Leukocyte Surface Antigen CD47 Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Leukocyte Surface Antigen CD47 Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Leukocyte Surface Antigen CD47 Producers in 2025
Table 18. World Leukocyte Surface Antigen CD47 Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Leukocyte Surface Antigen CD47 Producers in 2025
Table 20. World Leukocyte Surface Antigen CD47 Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Leukocyte Surface Antigen CD47 Company Evaluation Quadrant
Table 22. World Leukocyte Surface Antigen CD47 Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Leukocyte Surface Antigen CD47 Production Site of Key Manufacturer
Table 24. Leukocyte Surface Antigen CD47 Market: Company Product Type Footprint
Table 25. Leukocyte Surface Antigen CD47 Market: Company Product Application Footprint
Table 26. Leukocyte Surface Antigen CD47 Competitive Factors
Table 27. Leukocyte Surface Antigen CD47 New Entrant and Capacity Expansion Plans
Table 28. Leukocyte Surface Antigen CD47 Mergers & Acquisitions Activity
Table 29. United States VS China Leukocyte Surface Antigen CD47 Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Leukocyte Surface Antigen CD47 Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Leukocyte Surface Antigen CD47 Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Leukocyte Surface Antigen CD47 Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Leukocyte Surface Antigen CD47 Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Leukocyte Surface Antigen CD47 Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share (2021-2026)
Table 37. China Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Leukocyte Surface Antigen CD47 Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Leukocyte Surface Antigen CD47 Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Leukocyte Surface Antigen CD47 Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share (2021-2026)
Table 42. Rest of World Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share (2021-2026)
Table 47. World Leukocyte Surface Antigen CD47 Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Leukocyte Surface Antigen CD47 Production by Type (2021-2026) & (K Dose)
Table 49. World Leukocyte Surface Antigen CD47 Production by Type (2027-2032) & (K Dose)
Table 50. World Leukocyte Surface Antigen CD47 Production Value by Type (2021-2026) & (USD Million)
Table 51. World Leukocyte Surface Antigen CD47 Production Value by Type (2027-2032) & (USD Million)
Table 52. World Leukocyte Surface Antigen CD47 Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Leukocyte Surface Antigen CD47 Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Leukocyte Surface Antigen CD47 Production Value by Commercial Product Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Leukocyte Surface Antigen CD47 Production by Commercial Product Form (2021-2026) & (K Dose)
Table 56. World Leukocyte Surface Antigen CD47 Production by Commercial Product Form (2027-2032) & (K Dose)
Table 57. World Leukocyte Surface Antigen CD47 Production Value by Commercial Product Form (2021-2026) & (USD Million)
Table 58. World Leukocyte Surface Antigen CD47 Production Value by Commercial Product Form (2027-2032) & (USD Million)
Table 59. World Leukocyte Surface Antigen CD47 Average Price by Commercial Product Form (2021-2026) & (US$/Dose)
Table 60. World Leukocyte Surface Antigen CD47 Average Price by Commercial Product Form (2027-2032) & (US$/Dose)
Table 61. World Leukocyte Surface Antigen CD47 Production Value by Molecular Modality, (USD Million), 2021 & 2025 & 2032
Table 62. World Leukocyte Surface Antigen CD47 Production by Molecular Modality (2021-2026) & (K Dose)
Table 63. World Leukocyte Surface Antigen CD47 Production by Molecular Modality (2027-2032) & (K Dose)
Table 64. World Leukocyte Surface Antigen CD47 Production Value by Molecular Modality (2021-2026) & (USD Million)
Table 65. World Leukocyte Surface Antigen CD47 Production Value by Molecular Modality (2027-2032) & (USD Million)
Table 66. World Leukocyte Surface Antigen CD47 Average Price by Molecular Modality (2021-2026) & (US$/Dose)
Table 67. World Leukocyte Surface Antigen CD47 Average Price by Molecular Modality (2027-2032) & (US$/Dose)
Table 68. World Leukocyte Surface Antigen CD47 Production Value by Manufacturing System, (USD Million), 2021 & 2025 & 2032
Table 69. World Leukocyte Surface Antigen CD47 Production by Manufacturing System (2021-2026) & (K Dose)
Table 70. World Leukocyte Surface Antigen CD47 Production by Manufacturing System (2027-2032) & (K Dose)
Table 71. World Leukocyte Surface Antigen CD47 Production Value by Manufacturing System (2021-2026) & (USD Million)
Table 72. World Leukocyte Surface Antigen CD47 Production Value by Manufacturing System (2027-2032) & (USD Million)
Table 73. World Leukocyte Surface Antigen CD47 Average Price by Manufacturing System (2021-2026) & (US$/Dose)
Table 74. World Leukocyte Surface Antigen CD47 Average Price by Manufacturing System (2027-2032) & (US$/Dose)
Table 75. World Leukocyte Surface Antigen CD47 Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Leukocyte Surface Antigen CD47 Production by Application (2021-2026) & (K Dose)
Table 77. World Leukocyte Surface Antigen CD47 Production by Application (2027-2032) & (K Dose)
Table 78. World Leukocyte Surface Antigen CD47 Production Value by Application (2021-2026) & (USD Million)
Table 79. World Leukocyte Surface Antigen CD47 Production Value by Application (2027-2032) & (USD Million)
Table 80. World Leukocyte Surface Antigen CD47 Average Price by Application (2021-2026) & (US$/Dose)
Table 81. World Leukocyte Surface Antigen CD47 Average Price by Application (2027-2032) & (US$/Dose)
Table 82. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 83. Thermo Fisher Scientific Major Business
Table 84. Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Product and Services
Table 85. Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Thermo Fisher Scientific Recent Developments/Updates
Table 87. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 88. Merck Basic Information, Manufacturing Base and Competitors
Table 89. Merck Major Business
Table 90. Merck Leukocyte Surface Antigen CD47 Product and Services
Table 91. Merck Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Merck Recent Developments/Updates
Table 93. Merck Competitive Strengths & Weaknesses
Table 94. BD Biosciences Basic Information, Manufacturing Base and Competitors
Table 95. BD Biosciences Major Business
Table 96. BD Biosciences Leukocyte Surface Antigen CD47 Product and Services
Table 97. BD Biosciences Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. BD Biosciences Recent Developments/Updates
Table 99. BD Biosciences Competitive Strengths & Weaknesses
Table 100. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 101. Bio-Techne Major Business
Table 102. Bio-Techne Leukocyte Surface Antigen CD47 Product and Services
Table 103. Bio-Techne Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Bio-Techne Recent Developments/Updates
Table 105. Bio-Techne Competitive Strengths & Weaknesses
Table 106. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 107. Bio-Rad Major Business
Table 108. Bio-Rad Leukocyte Surface Antigen CD47 Product and Services
Table 109. Bio-Rad Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Bio-Rad Recent Developments/Updates
Table 111. Bio-Rad Competitive Strengths & Weaknesses
Table 112. Revvity BioLegend Basic Information, Manufacturing Base and Competitors
Table 113. Revvity BioLegend Major Business
Table 114. Revvity BioLegend Leukocyte Surface Antigen CD47 Product and Services
Table 115. Revvity BioLegend Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Revvity BioLegend Recent Developments/Updates
Table 117. Revvity BioLegend Competitive Strengths & Weaknesses
Table 118. Abcam Basic Information, Manufacturing Base and Competitors
Table 119. Abcam Major Business
Table 120. Abcam Leukocyte Surface Antigen CD47 Product and Services
Table 121. Abcam Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Abcam Recent Developments/Updates
Table 123. Abcam Competitive Strengths & Weaknesses
Table 124. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 125. Miltenyi Biotec Major Business
Table 126. Miltenyi Biotec Leukocyte Surface Antigen CD47 Product and Services
Table 127. Miltenyi Biotec Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Miltenyi Biotec Recent Developments/Updates
Table 129. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 130. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 131. Cell Signaling Technology Major Business
Table 132. Cell Signaling Technology Leukocyte Surface Antigen CD47 Product and Services
Table 133. Cell Signaling Technology Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Cell Signaling Technology Recent Developments/Updates
Table 135. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 136. Proteintech Basic Information, Manufacturing Base and Competitors
Table 137. Proteintech Major Business
Table 138. Proteintech Leukocyte Surface Antigen CD47 Product and Services
Table 139. Proteintech Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Proteintech Recent Developments/Updates
Table 141. Proteintech Competitive Strengths & Weaknesses
Table 142. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 143. Sino Biological Major Business
Table 144. Sino Biological Leukocyte Surface Antigen CD47 Product and Services
Table 145. Sino Biological Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. Sino Biological Recent Developments/Updates
Table 147. Sino Biological Competitive Strengths & Weaknesses
Table 148. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 149. ACROBiosystems Major Business
Table 150. ACROBiosystems Leukocyte Surface Antigen CD47 Product and Services
Table 151. ACROBiosystems Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 152. ACROBiosystems Recent Developments/Updates
Table 153. ACROBiosystems Competitive Strengths & Weaknesses
Table 154. MedChemExpress Basic Information, Manufacturing Base and Competitors
Table 155. MedChemExpress Major Business
Table 156. MedChemExpress Leukocyte Surface Antigen CD47 Product and Services
Table 157. MedChemExpress Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 158. MedChemExpress Recent Developments/Updates
Table 159. MedChemExpress Competitive Strengths & Weaknesses
Table 160. OriGene Basic Information, Manufacturing Base and Competitors
Table 161. OriGene Major Business
Table 162. OriGene Leukocyte Surface Antigen CD47 Product and Services
Table 163. OriGene Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 164. OriGene Recent Developments/Updates
Table 165. OriGene Competitive Strengths & Weaknesses
Table 166. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 167. Santa Cruz Biotechnology Major Business
Table 168. Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Product and Services
Table 169. Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Santa Cruz Biotechnology Recent Developments/Updates
Table 171. Santa Cruz Biotechnology Competitive Strengths & Weaknesses
Table 172. Bio X Cell Basic Information, Manufacturing Base and Competitors
Table 173. Bio X Cell Major Business
Table 174. Bio X Cell Leukocyte Surface Antigen CD47 Product and Services
Table 175. Bio X Cell Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 176. Bio X Cell Recent Developments/Updates
Table 177. Bio X Cell Competitive Strengths & Weaknesses
Table 178. Leinco Technologies Basic Information, Manufacturing Base and Competitors
Table 179. Leinco Technologies Major Business
Table 180. Leinco Technologies Leukocyte Surface Antigen CD47 Product and Services
Table 181. Leinco Technologies Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 182. Leinco Technologies Recent Developments/Updates
Table 183. Leinco Technologies Competitive Strengths & Weaknesses
Table 184. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 185. RayBiotech Major Business
Table 186. RayBiotech Leukocyte Surface Antigen CD47 Product and Services
Table 187. RayBiotech Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 188. RayBiotech Recent Developments/Updates
Table 189. RayBiotech Competitive Strengths & Weaknesses
Table 190. Cytek Biosciences Basic Information, Manufacturing Base and Competitors
Table 191. Cytek Biosciences Major Business
Table 192. Cytek Biosciences Leukocyte Surface Antigen CD47 Product and Services
Table 193. Cytek Biosciences Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 194. Cytek Biosciences Recent Developments/Updates
Table 195. Cytek Biosciences Competitive Strengths & Weaknesses
Table 196. Biocare Medical Basic Information, Manufacturing Base and Competitors
Table 197. Biocare Medical Major Business
Table 198. Biocare Medical Leukocyte Surface Antigen CD47 Product and Services
Table 199. Biocare Medical Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Biocare Medical Recent Developments/Updates
Table 201. Biocare Medical Competitive Strengths & Weaknesses
Table 202. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 203. Creative Biolabs Major Business
Table 204. Creative Biolabs Leukocyte Surface Antigen CD47 Product and Services
Table 205. Creative Biolabs Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 206. Creative Biolabs Recent Developments/Updates
Table 207. Creative Biolabs Competitive Strengths & Weaknesses
Table 208. BPS Bioscience Basic Information, Manufacturing Base and Competitors
Table 209. BPS Bioscience Major Business
Table 210. BPS Bioscience Leukocyte Surface Antigen CD47 Product and Services
Table 211. BPS Bioscience Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 212. BPS Bioscience Recent Developments/Updates
Table 213. BPS Bioscience Competitive Strengths & Weaknesses
Table 214. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 215. MyBioSource Major Business
Table 216. MyBioSource Leukocyte Surface Antigen CD47 Product and Services
Table 217. MyBioSource Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 218. MyBioSource Recent Developments/Updates
Table 219. MyBioSource Competitive Strengths & Weaknesses
Table 220. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 221. Novus Biologicals Major Business
Table 222. Novus Biologicals Leukocyte Surface Antigen CD47 Product and Services
Table 223. Novus Biologicals Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 224. Novus Biologicals Recent Developments/Updates
Table 225. Novus Biologicals Competitive Strengths & Weaknesses
Table 226. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 227. Aviva Systems Biology Major Business
Table 228. Aviva Systems Biology Leukocyte Surface Antigen CD47 Product and Services
Table 229. Aviva Systems Biology Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 230. Aviva Systems Biology Recent Developments/Updates
Table 231. Aviva Systems Biology Competitive Strengths & Weaknesses
Table 232. Bioss Basic Information, Manufacturing Base and Competitors
Table 233. Bioss Major Business
Table 234. Bioss Leukocyte Surface Antigen CD47 Product and Services
Table 235. Bioss Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 236. Bioss Recent Developments/Updates
Table 237. Bioss Competitive Strengths & Weaknesses
Table 238. Innovative Research Basic Information, Manufacturing Base and Competitors
Table 239. Innovative Research Major Business
Table 240. Innovative Research Leukocyte Surface Antigen CD47 Product and Services
Table 241. Innovative Research Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 242. Innovative Research Recent Developments/Updates
Table 243. Innovative Research Competitive Strengths & Weaknesses
Table 244. Antibodies.com Basic Information, Manufacturing Base and Competitors
Table 245. Antibodies.com Major Business
Table 246. Antibodies.com Leukocyte Surface Antigen CD47 Product and Services
Table 247. Antibodies.com Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 248. Antibodies.com Recent Developments/Updates
Table 249. Antibodies.com Competitive Strengths & Weaknesses
Table 250. Abbexa Basic Information, Manufacturing Base and Competitors
Table 251. Abbexa Major Business
Table 252. Abbexa Leukocyte Surface Antigen CD47 Product and Services
Table 253. Abbexa Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 254. Abbexa Recent Developments/Updates
Table 255. Abbexa Competitive Strengths & Weaknesses
Table 256. Arigo Biolaboratories Basic Information, Manufacturing Base and Competitors
Table 257. Arigo Biolaboratories Major Business
Table 258. Arigo Biolaboratories Leukocyte Surface Antigen CD47 Product and Services
Table 259. Arigo Biolaboratories Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 260. Arigo Biolaboratories Recent Developments/Updates
Table 261. Arigo Biolaboratories Competitive Strengths & Weaknesses
Table 262. Abnova Basic Information, Manufacturing Base and Competitors
Table 263. Abnova Major Business
Table 264. Abnova Leukocyte Surface Antigen CD47 Product and Services
Table 265. Abnova Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 266. Abnova Recent Developments/Updates
Table 267. Abnova Competitive Strengths & Weaknesses
Table 268. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 269. CUSABIO Major Business
Table 270. CUSABIO Leukocyte Surface Antigen CD47 Product and Services
Table 271. CUSABIO Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 272. CUSABIO Recent Developments/Updates
Table 273. CUSABIO Competitive Strengths & Weaknesses
Table 274. Elabscience Basic Information, Manufacturing Base and Competitors
Table 275. Elabscience Major Business
Table 276. Elabscience Leukocyte Surface Antigen CD47 Product and Services
Table 277. Elabscience Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 278. Elabscience Recent Developments/Updates
Table 279. Elabscience Competitive Strengths & Weaknesses
Table 280. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 281. Boster Biological Technology Major Business
Table 282. Boster Biological Technology Leukocyte Surface Antigen CD47 Product and Services
Table 283. Boster Biological Technology Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 284. Boster Biological Technology Recent Developments/Updates
Table 285. Boster Biological Technology Competitive Strengths & Weaknesses
Table 286. ABclonal Basic Information, Manufacturing Base and Competitors
Table 287. ABclonal Major Business
Table 288. ABclonal Leukocyte Surface Antigen CD47 Product and Services
Table 289. ABclonal Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 290. ABclonal Recent Developments/Updates
Table 291. ABclonal Competitive Strengths & Weaknesses
Table 292. Sangon Biotech Basic Information, Manufacturing Base and Competitors
Table 293. Sangon Biotech Major Business
Table 294. Sangon Biotech Leukocyte Surface Antigen CD47 Product and Services
Table 295. Sangon Biotech Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 296. Sangon Biotech Recent Developments/Updates
Table 297. Sangon Biotech Competitive Strengths & Weaknesses
Table 298. Cloud-Clone Basic Information, Manufacturing Base and Competitors
Table 299. Cloud-Clone Major Business
Table 300. Cloud-Clone Leukocyte Surface Antigen CD47 Product and Services
Table 301. Cloud-Clone Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 302. Cloud-Clone Recent Developments/Updates
Table 303. Cloud-Clone Competitive Strengths & Weaknesses
Table 304. Akeso Basic Information, Manufacturing Base and Competitors
Table 305. Akeso Major Business
Table 306. Akeso Leukocyte Surface Antigen CD47 Product and Services
Table 307. Akeso Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 308. Akeso Recent Developments/Updates
Table 309. Akeso Competitive Strengths & Weaknesses
Table 310. 3D Medicines Basic Information, Manufacturing Base and Competitors
Table 311. 3D Medicines Major Business
Table 312. 3D Medicines Leukocyte Surface Antigen CD47 Product and Services
Table 313. 3D Medicines Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 314. 3D Medicines Recent Developments/Updates
Table 315. 3D Medicines Competitive Strengths & Weaknesses
Table 316. Fapon Biopharma Basic Information, Manufacturing Base and Competitors
Table 317. Fapon Biopharma Major Business
Table 318. Fapon Biopharma Leukocyte Surface Antigen CD47 Product and Services
Table 319. Fapon Biopharma Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 320. Fapon Biopharma Recent Developments/Updates
Table 321. Fapon Biopharma Competitive Strengths & Weaknesses
Table 322. Global Key Players of Leukocyte Surface Antigen CD47 Upstream (Raw Materials)
Table 323. Global Leukocyte Surface Antigen CD47 Typical Customers
Table 324. Leukocyte Surface Antigen CD47 Typical Distributors
Table 1. World Leukocyte Surface Antigen CD47 Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Leukocyte Surface Antigen CD47 Production Value by Region (2021-2026) & (USD Million)
Table 3. World Leukocyte Surface Antigen CD47 Production Value by Region (2027-2032) & (USD Million)
Table 4. World Leukocyte Surface Antigen CD47 Production Value Market Share by Region (2021-2026)
Table 5. World Leukocyte Surface Antigen CD47 Production Value Market Share by Region (2027-2032)
Table 6. World Leukocyte Surface Antigen CD47 Production by Region (2021-2026) & (K Dose)
Table 7. World Leukocyte Surface Antigen CD47 Production by Region (2027-2032) & (K Dose)
Table 8. World Leukocyte Surface Antigen CD47 Production Market Share by Region (2021-2026)
Table 9. World Leukocyte Surface Antigen CD47 Production Market Share by Region (2027-2032)
Table 10. World Leukocyte Surface Antigen CD47 Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Leukocyte Surface Antigen CD47 Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Leukocyte Surface Antigen CD47 Major Market Trends
Table 13. World Leukocyte Surface Antigen CD47 Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Leukocyte Surface Antigen CD47 Consumption by Region (2021-2026) & (K Dose)
Table 15. World Leukocyte Surface Antigen CD47 Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Leukocyte Surface Antigen CD47 Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Leukocyte Surface Antigen CD47 Producers in 2025
Table 18. World Leukocyte Surface Antigen CD47 Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Leukocyte Surface Antigen CD47 Producers in 2025
Table 20. World Leukocyte Surface Antigen CD47 Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Leukocyte Surface Antigen CD47 Company Evaluation Quadrant
Table 22. World Leukocyte Surface Antigen CD47 Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Leukocyte Surface Antigen CD47 Production Site of Key Manufacturer
Table 24. Leukocyte Surface Antigen CD47 Market: Company Product Type Footprint
Table 25. Leukocyte Surface Antigen CD47 Market: Company Product Application Footprint
Table 26. Leukocyte Surface Antigen CD47 Competitive Factors
Table 27. Leukocyte Surface Antigen CD47 New Entrant and Capacity Expansion Plans
Table 28. Leukocyte Surface Antigen CD47 Mergers & Acquisitions Activity
Table 29. United States VS China Leukocyte Surface Antigen CD47 Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Leukocyte Surface Antigen CD47 Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Leukocyte Surface Antigen CD47 Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Leukocyte Surface Antigen CD47 Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Leukocyte Surface Antigen CD47 Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Leukocyte Surface Antigen CD47 Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share (2021-2026)
Table 37. China Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Leukocyte Surface Antigen CD47 Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Leukocyte Surface Antigen CD47 Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Leukocyte Surface Antigen CD47 Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share (2021-2026)
Table 42. Rest of World Based Leukocyte Surface Antigen CD47 Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share (2021-2026)
Table 47. World Leukocyte Surface Antigen CD47 Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Leukocyte Surface Antigen CD47 Production by Type (2021-2026) & (K Dose)
Table 49. World Leukocyte Surface Antigen CD47 Production by Type (2027-2032) & (K Dose)
Table 50. World Leukocyte Surface Antigen CD47 Production Value by Type (2021-2026) & (USD Million)
Table 51. World Leukocyte Surface Antigen CD47 Production Value by Type (2027-2032) & (USD Million)
Table 52. World Leukocyte Surface Antigen CD47 Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Leukocyte Surface Antigen CD47 Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Leukocyte Surface Antigen CD47 Production Value by Commercial Product Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Leukocyte Surface Antigen CD47 Production by Commercial Product Form (2021-2026) & (K Dose)
Table 56. World Leukocyte Surface Antigen CD47 Production by Commercial Product Form (2027-2032) & (K Dose)
Table 57. World Leukocyte Surface Antigen CD47 Production Value by Commercial Product Form (2021-2026) & (USD Million)
Table 58. World Leukocyte Surface Antigen CD47 Production Value by Commercial Product Form (2027-2032) & (USD Million)
Table 59. World Leukocyte Surface Antigen CD47 Average Price by Commercial Product Form (2021-2026) & (US$/Dose)
Table 60. World Leukocyte Surface Antigen CD47 Average Price by Commercial Product Form (2027-2032) & (US$/Dose)
Table 61. World Leukocyte Surface Antigen CD47 Production Value by Molecular Modality, (USD Million), 2021 & 2025 & 2032
Table 62. World Leukocyte Surface Antigen CD47 Production by Molecular Modality (2021-2026) & (K Dose)
Table 63. World Leukocyte Surface Antigen CD47 Production by Molecular Modality (2027-2032) & (K Dose)
Table 64. World Leukocyte Surface Antigen CD47 Production Value by Molecular Modality (2021-2026) & (USD Million)
Table 65. World Leukocyte Surface Antigen CD47 Production Value by Molecular Modality (2027-2032) & (USD Million)
Table 66. World Leukocyte Surface Antigen CD47 Average Price by Molecular Modality (2021-2026) & (US$/Dose)
Table 67. World Leukocyte Surface Antigen CD47 Average Price by Molecular Modality (2027-2032) & (US$/Dose)
Table 68. World Leukocyte Surface Antigen CD47 Production Value by Manufacturing System, (USD Million), 2021 & 2025 & 2032
Table 69. World Leukocyte Surface Antigen CD47 Production by Manufacturing System (2021-2026) & (K Dose)
Table 70. World Leukocyte Surface Antigen CD47 Production by Manufacturing System (2027-2032) & (K Dose)
Table 71. World Leukocyte Surface Antigen CD47 Production Value by Manufacturing System (2021-2026) & (USD Million)
Table 72. World Leukocyte Surface Antigen CD47 Production Value by Manufacturing System (2027-2032) & (USD Million)
Table 73. World Leukocyte Surface Antigen CD47 Average Price by Manufacturing System (2021-2026) & (US$/Dose)
Table 74. World Leukocyte Surface Antigen CD47 Average Price by Manufacturing System (2027-2032) & (US$/Dose)
Table 75. World Leukocyte Surface Antigen CD47 Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Leukocyte Surface Antigen CD47 Production by Application (2021-2026) & (K Dose)
Table 77. World Leukocyte Surface Antigen CD47 Production by Application (2027-2032) & (K Dose)
Table 78. World Leukocyte Surface Antigen CD47 Production Value by Application (2021-2026) & (USD Million)
Table 79. World Leukocyte Surface Antigen CD47 Production Value by Application (2027-2032) & (USD Million)
Table 80. World Leukocyte Surface Antigen CD47 Average Price by Application (2021-2026) & (US$/Dose)
Table 81. World Leukocyte Surface Antigen CD47 Average Price by Application (2027-2032) & (US$/Dose)
Table 82. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 83. Thermo Fisher Scientific Major Business
Table 84. Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Product and Services
Table 85. Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Thermo Fisher Scientific Recent Developments/Updates
Table 87. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 88. Merck Basic Information, Manufacturing Base and Competitors
Table 89. Merck Major Business
Table 90. Merck Leukocyte Surface Antigen CD47 Product and Services
Table 91. Merck Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Merck Recent Developments/Updates
Table 93. Merck Competitive Strengths & Weaknesses
Table 94. BD Biosciences Basic Information, Manufacturing Base and Competitors
Table 95. BD Biosciences Major Business
Table 96. BD Biosciences Leukocyte Surface Antigen CD47 Product and Services
Table 97. BD Biosciences Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. BD Biosciences Recent Developments/Updates
Table 99. BD Biosciences Competitive Strengths & Weaknesses
Table 100. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 101. Bio-Techne Major Business
Table 102. Bio-Techne Leukocyte Surface Antigen CD47 Product and Services
Table 103. Bio-Techne Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Bio-Techne Recent Developments/Updates
Table 105. Bio-Techne Competitive Strengths & Weaknesses
Table 106. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 107. Bio-Rad Major Business
Table 108. Bio-Rad Leukocyte Surface Antigen CD47 Product and Services
Table 109. Bio-Rad Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Bio-Rad Recent Developments/Updates
Table 111. Bio-Rad Competitive Strengths & Weaknesses
Table 112. Revvity BioLegend Basic Information, Manufacturing Base and Competitors
Table 113. Revvity BioLegend Major Business
Table 114. Revvity BioLegend Leukocyte Surface Antigen CD47 Product and Services
Table 115. Revvity BioLegend Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Revvity BioLegend Recent Developments/Updates
Table 117. Revvity BioLegend Competitive Strengths & Weaknesses
Table 118. Abcam Basic Information, Manufacturing Base and Competitors
Table 119. Abcam Major Business
Table 120. Abcam Leukocyte Surface Antigen CD47 Product and Services
Table 121. Abcam Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Abcam Recent Developments/Updates
Table 123. Abcam Competitive Strengths & Weaknesses
Table 124. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 125. Miltenyi Biotec Major Business
Table 126. Miltenyi Biotec Leukocyte Surface Antigen CD47 Product and Services
Table 127. Miltenyi Biotec Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Miltenyi Biotec Recent Developments/Updates
Table 129. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 130. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 131. Cell Signaling Technology Major Business
Table 132. Cell Signaling Technology Leukocyte Surface Antigen CD47 Product and Services
Table 133. Cell Signaling Technology Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Cell Signaling Technology Recent Developments/Updates
Table 135. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 136. Proteintech Basic Information, Manufacturing Base and Competitors
Table 137. Proteintech Major Business
Table 138. Proteintech Leukocyte Surface Antigen CD47 Product and Services
Table 139. Proteintech Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Proteintech Recent Developments/Updates
Table 141. Proteintech Competitive Strengths & Weaknesses
Table 142. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 143. Sino Biological Major Business
Table 144. Sino Biological Leukocyte Surface Antigen CD47 Product and Services
Table 145. Sino Biological Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. Sino Biological Recent Developments/Updates
Table 147. Sino Biological Competitive Strengths & Weaknesses
Table 148. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 149. ACROBiosystems Major Business
Table 150. ACROBiosystems Leukocyte Surface Antigen CD47 Product and Services
Table 151. ACROBiosystems Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 152. ACROBiosystems Recent Developments/Updates
Table 153. ACROBiosystems Competitive Strengths & Weaknesses
Table 154. MedChemExpress Basic Information, Manufacturing Base and Competitors
Table 155. MedChemExpress Major Business
Table 156. MedChemExpress Leukocyte Surface Antigen CD47 Product and Services
Table 157. MedChemExpress Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 158. MedChemExpress Recent Developments/Updates
Table 159. MedChemExpress Competitive Strengths & Weaknesses
Table 160. OriGene Basic Information, Manufacturing Base and Competitors
Table 161. OriGene Major Business
Table 162. OriGene Leukocyte Surface Antigen CD47 Product and Services
Table 163. OriGene Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 164. OriGene Recent Developments/Updates
Table 165. OriGene Competitive Strengths & Weaknesses
Table 166. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 167. Santa Cruz Biotechnology Major Business
Table 168. Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Product and Services
Table 169. Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Santa Cruz Biotechnology Recent Developments/Updates
Table 171. Santa Cruz Biotechnology Competitive Strengths & Weaknesses
Table 172. Bio X Cell Basic Information, Manufacturing Base and Competitors
Table 173. Bio X Cell Major Business
Table 174. Bio X Cell Leukocyte Surface Antigen CD47 Product and Services
Table 175. Bio X Cell Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 176. Bio X Cell Recent Developments/Updates
Table 177. Bio X Cell Competitive Strengths & Weaknesses
Table 178. Leinco Technologies Basic Information, Manufacturing Base and Competitors
Table 179. Leinco Technologies Major Business
Table 180. Leinco Technologies Leukocyte Surface Antigen CD47 Product and Services
Table 181. Leinco Technologies Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 182. Leinco Technologies Recent Developments/Updates
Table 183. Leinco Technologies Competitive Strengths & Weaknesses
Table 184. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 185. RayBiotech Major Business
Table 186. RayBiotech Leukocyte Surface Antigen CD47 Product and Services
Table 187. RayBiotech Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 188. RayBiotech Recent Developments/Updates
Table 189. RayBiotech Competitive Strengths & Weaknesses
Table 190. Cytek Biosciences Basic Information, Manufacturing Base and Competitors
Table 191. Cytek Biosciences Major Business
Table 192. Cytek Biosciences Leukocyte Surface Antigen CD47 Product and Services
Table 193. Cytek Biosciences Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 194. Cytek Biosciences Recent Developments/Updates
Table 195. Cytek Biosciences Competitive Strengths & Weaknesses
Table 196. Biocare Medical Basic Information, Manufacturing Base and Competitors
Table 197. Biocare Medical Major Business
Table 198. Biocare Medical Leukocyte Surface Antigen CD47 Product and Services
Table 199. Biocare Medical Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Biocare Medical Recent Developments/Updates
Table 201. Biocare Medical Competitive Strengths & Weaknesses
Table 202. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 203. Creative Biolabs Major Business
Table 204. Creative Biolabs Leukocyte Surface Antigen CD47 Product and Services
Table 205. Creative Biolabs Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 206. Creative Biolabs Recent Developments/Updates
Table 207. Creative Biolabs Competitive Strengths & Weaknesses
Table 208. BPS Bioscience Basic Information, Manufacturing Base and Competitors
Table 209. BPS Bioscience Major Business
Table 210. BPS Bioscience Leukocyte Surface Antigen CD47 Product and Services
Table 211. BPS Bioscience Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 212. BPS Bioscience Recent Developments/Updates
Table 213. BPS Bioscience Competitive Strengths & Weaknesses
Table 214. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 215. MyBioSource Major Business
Table 216. MyBioSource Leukocyte Surface Antigen CD47 Product and Services
Table 217. MyBioSource Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 218. MyBioSource Recent Developments/Updates
Table 219. MyBioSource Competitive Strengths & Weaknesses
Table 220. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 221. Novus Biologicals Major Business
Table 222. Novus Biologicals Leukocyte Surface Antigen CD47 Product and Services
Table 223. Novus Biologicals Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 224. Novus Biologicals Recent Developments/Updates
Table 225. Novus Biologicals Competitive Strengths & Weaknesses
Table 226. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 227. Aviva Systems Biology Major Business
Table 228. Aviva Systems Biology Leukocyte Surface Antigen CD47 Product and Services
Table 229. Aviva Systems Biology Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 230. Aviva Systems Biology Recent Developments/Updates
Table 231. Aviva Systems Biology Competitive Strengths & Weaknesses
Table 232. Bioss Basic Information, Manufacturing Base and Competitors
Table 233. Bioss Major Business
Table 234. Bioss Leukocyte Surface Antigen CD47 Product and Services
Table 235. Bioss Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 236. Bioss Recent Developments/Updates
Table 237. Bioss Competitive Strengths & Weaknesses
Table 238. Innovative Research Basic Information, Manufacturing Base and Competitors
Table 239. Innovative Research Major Business
Table 240. Innovative Research Leukocyte Surface Antigen CD47 Product and Services
Table 241. Innovative Research Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 242. Innovative Research Recent Developments/Updates
Table 243. Innovative Research Competitive Strengths & Weaknesses
Table 244. Antibodies.com Basic Information, Manufacturing Base and Competitors
Table 245. Antibodies.com Major Business
Table 246. Antibodies.com Leukocyte Surface Antigen CD47 Product and Services
Table 247. Antibodies.com Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 248. Antibodies.com Recent Developments/Updates
Table 249. Antibodies.com Competitive Strengths & Weaknesses
Table 250. Abbexa Basic Information, Manufacturing Base and Competitors
Table 251. Abbexa Major Business
Table 252. Abbexa Leukocyte Surface Antigen CD47 Product and Services
Table 253. Abbexa Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 254. Abbexa Recent Developments/Updates
Table 255. Abbexa Competitive Strengths & Weaknesses
Table 256. Arigo Biolaboratories Basic Information, Manufacturing Base and Competitors
Table 257. Arigo Biolaboratories Major Business
Table 258. Arigo Biolaboratories Leukocyte Surface Antigen CD47 Product and Services
Table 259. Arigo Biolaboratories Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 260. Arigo Biolaboratories Recent Developments/Updates
Table 261. Arigo Biolaboratories Competitive Strengths & Weaknesses
Table 262. Abnova Basic Information, Manufacturing Base and Competitors
Table 263. Abnova Major Business
Table 264. Abnova Leukocyte Surface Antigen CD47 Product and Services
Table 265. Abnova Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 266. Abnova Recent Developments/Updates
Table 267. Abnova Competitive Strengths & Weaknesses
Table 268. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 269. CUSABIO Major Business
Table 270. CUSABIO Leukocyte Surface Antigen CD47 Product and Services
Table 271. CUSABIO Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 272. CUSABIO Recent Developments/Updates
Table 273. CUSABIO Competitive Strengths & Weaknesses
Table 274. Elabscience Basic Information, Manufacturing Base and Competitors
Table 275. Elabscience Major Business
Table 276. Elabscience Leukocyte Surface Antigen CD47 Product and Services
Table 277. Elabscience Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 278. Elabscience Recent Developments/Updates
Table 279. Elabscience Competitive Strengths & Weaknesses
Table 280. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 281. Boster Biological Technology Major Business
Table 282. Boster Biological Technology Leukocyte Surface Antigen CD47 Product and Services
Table 283. Boster Biological Technology Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 284. Boster Biological Technology Recent Developments/Updates
Table 285. Boster Biological Technology Competitive Strengths & Weaknesses
Table 286. ABclonal Basic Information, Manufacturing Base and Competitors
Table 287. ABclonal Major Business
Table 288. ABclonal Leukocyte Surface Antigen CD47 Product and Services
Table 289. ABclonal Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 290. ABclonal Recent Developments/Updates
Table 291. ABclonal Competitive Strengths & Weaknesses
Table 292. Sangon Biotech Basic Information, Manufacturing Base and Competitors
Table 293. Sangon Biotech Major Business
Table 294. Sangon Biotech Leukocyte Surface Antigen CD47 Product and Services
Table 295. Sangon Biotech Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 296. Sangon Biotech Recent Developments/Updates
Table 297. Sangon Biotech Competitive Strengths & Weaknesses
Table 298. Cloud-Clone Basic Information, Manufacturing Base and Competitors
Table 299. Cloud-Clone Major Business
Table 300. Cloud-Clone Leukocyte Surface Antigen CD47 Product and Services
Table 301. Cloud-Clone Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 302. Cloud-Clone Recent Developments/Updates
Table 303. Cloud-Clone Competitive Strengths & Weaknesses
Table 304. Akeso Basic Information, Manufacturing Base and Competitors
Table 305. Akeso Major Business
Table 306. Akeso Leukocyte Surface Antigen CD47 Product and Services
Table 307. Akeso Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 308. Akeso Recent Developments/Updates
Table 309. Akeso Competitive Strengths & Weaknesses
Table 310. 3D Medicines Basic Information, Manufacturing Base and Competitors
Table 311. 3D Medicines Major Business
Table 312. 3D Medicines Leukocyte Surface Antigen CD47 Product and Services
Table 313. 3D Medicines Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 314. 3D Medicines Recent Developments/Updates
Table 315. 3D Medicines Competitive Strengths & Weaknesses
Table 316. Fapon Biopharma Basic Information, Manufacturing Base and Competitors
Table 317. Fapon Biopharma Major Business
Table 318. Fapon Biopharma Leukocyte Surface Antigen CD47 Product and Services
Table 319. Fapon Biopharma Leukocyte Surface Antigen CD47 Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 320. Fapon Biopharma Recent Developments/Updates
Table 321. Fapon Biopharma Competitive Strengths & Weaknesses
Table 322. Global Key Players of Leukocyte Surface Antigen CD47 Upstream (Raw Materials)
Table 323. Global Leukocyte Surface Antigen CD47 Typical Customers
Table 324. Leukocyte Surface Antigen CD47 Typical Distributors
LIST OF FIGURES
Figure 1. Leukocyte Surface Antigen CD47 Picture
Figure 2. World Leukocyte Surface Antigen CD47 Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Leukocyte Surface Antigen CD47 Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 5. World Leukocyte Surface Antigen CD47 Average Price (2021-2032) & (US$/Dose)
Figure 6. World Leukocyte Surface Antigen CD47 Production Value Market Share by Region (2021-2032)
Figure 7. World Leukocyte Surface Antigen CD47 Production Market Share by Region (2021-2032)
Figure 8. North America Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 9. China Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 10. Europe Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 11. India Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 12. South Korea Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 13. Taiwan Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 14. Leukocyte Surface Antigen CD47 Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 17. World Leukocyte Surface Antigen CD47 Consumption Market Share by Region (2021-2032)
Figure 18. United States Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 19. China Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 20. Europe Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 21. Japan Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 22. South Korea Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 23. ASEAN Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 24. India Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 25. Producer Shipments of Leukocyte Surface Antigen CD47 by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Leukocyte Surface Antigen CD47 Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Leukocyte Surface Antigen CD47 Markets in 2025
Figure 28. United States VS China: Leukocyte Surface Antigen CD47 Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Leukocyte Surface Antigen CD47 Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Leukocyte Surface Antigen CD47 Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share 2025
Figure 32. China Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share 2025
Figure 34. World Leukocyte Surface Antigen CD47 Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Leukocyte Surface Antigen CD47 Production Value Market Share by Type in 2025
Figure 36. B-6H12
Figure 37. ALX-148
Figure 38. CC-90002
Figure 39. PSTx-23
Figure 40. Others
Figure 41. World Leukocyte Surface Antigen CD47 Production Market Share by Type (2021-2032)
Figure 42. World Leukocyte Surface Antigen CD47 Production Value Market Share by Type (2021-2032)
Figure 43. World Leukocyte Surface Antigen CD47 Average Price by Type (2021-2032) & (US$/Dose)
Figure 44. World Leukocyte Surface Antigen CD47 Production Value by Commercial Product Form, (USD Million), 2021 & 2025 & 2032
Figure 45. World Leukocyte Surface Antigen CD47 Production Value Market Share by Commercial Product Form in 2025
Figure 46. Anti-CD47 Antibodies
Figure 47. Recombinant CD47 Proteins
Figure 48. CD47 Assay Kits
Figure 49. Others
Figure 50. World Leukocyte Surface Antigen CD47 Production Market Share by Commercial Product Form (2021-2032)
Figure 51. World Leukocyte Surface Antigen CD47 Production Value Market Share by Commercial Product Form (2021-2032)
Figure 52. World Leukocyte Surface Antigen CD47 Average Price by Commercial Product Form (2021-2032) & (US$/Dose)
Figure 1. Leukocyte Surface Antigen CD47 Picture
Figure 2. World Leukocyte Surface Antigen CD47 Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Leukocyte Surface Antigen CD47 Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 5. World Leukocyte Surface Antigen CD47 Average Price (2021-2032) & (US$/Dose)
Figure 6. World Leukocyte Surface Antigen CD47 Production Value Market Share by Region (2021-2032)
Figure 7. World Leukocyte Surface Antigen CD47 Production Market Share by Region (2021-2032)
Figure 8. North America Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 9. China Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 10. Europe Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 11. India Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 12. South Korea Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 13. Taiwan Leukocyte Surface Antigen CD47 Production (2021-2032) & (K Dose)
Figure 14. Leukocyte Surface Antigen CD47 Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 17. World Leukocyte Surface Antigen CD47 Consumption Market Share by Region (2021-2032)
Figure 18. United States Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 19. China Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 20. Europe Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 21. Japan Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 22. South Korea Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 23. ASEAN Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 24. India Leukocyte Surface Antigen CD47 Consumption (2021-2032) & (K Dose)
Figure 25. Producer Shipments of Leukocyte Surface Antigen CD47 by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Leukocyte Surface Antigen CD47 Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Leukocyte Surface Antigen CD47 Markets in 2025
Figure 28. United States VS China: Leukocyte Surface Antigen CD47 Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Leukocyte Surface Antigen CD47 Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Leukocyte Surface Antigen CD47 Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share 2025
Figure 32. China Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Leukocyte Surface Antigen CD47 Production Market Share 2025
Figure 34. World Leukocyte Surface Antigen CD47 Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Leukocyte Surface Antigen CD47 Production Value Market Share by Type in 2025
Figure 36. B-6H12
Figure 37. ALX-148
Figure 38. CC-90002
Figure 39. PSTx-23
Figure 40. Others
Figure 41. World Leukocyte Surface Antigen CD47 Production Market Share by Type (2021-2032)
Figure 42. World Leukocyte Surface Antigen CD47 Production Value Market Share by Type (2021-2032)
Figure 43. World Leukocyte Surface Antigen CD47 Average Price by Type (2021-2032) & (US$/Dose)
Figure 44. World Leukocyte Surface Antigen CD47 Production Value by Commercial Product Form, (USD Million), 2021 & 2025 & 2032
Figure 45. World Leukocyte Surface Antigen CD47 Production Value Market Share by Commercial Product Form in 2025
Figure 46. Anti-CD47 Antibodies
Figure 47. Recombinant CD47 Proteins
Figure 48. CD47 Assay Kits
Figure 49. Others
Figure 50. World Leukocyte Surface Antigen CD47 Production Market Share by Commercial Product Form (2021-2032)
Figure 51. World Leukocyte Surface Antigen CD47 Production Value Market Share by Commercial Product Form (2021-2032)
Figure 52. World Leukocyte Surface Antigen CD47 Average Price by Commercial Product Form (2021-2032) & (US$/Dose)
